Silver Diamine Fluoride for Caries Prevention in Removable Partial Dentures Wearers

June 9, 2017 updated by: The University of Hong Kong

Randomized Double-blind Placebo-controlled Trial of Silver Diamine Fluoride for Caries Prevention in Removable Partial Dentures Wearers

This study measures and compares the effect of silver diamine fluoride (SDF) on caries increment in removable partial denture wearers. Half of the participants will SDF and while the other half will receive placebo.

Study Overview

Detailed Description

Removable partial dentures are commonly constructed to replace missing teeth. It is observed that removable partial denture wearers are susceptible to dental caries.

The mode of action of silver diamine fluoride on caries prevention is dual: fluoride ions interact synergistically with silver to react with hydroxyapatite to form fluorapatite, and silver is bactericidal by reacting with the thiol groups of the amino and nucleic acids that halt the metabolic and reproductive functions of the cariogenic bacteria.

Study Type

Interventional

Enrollment (Actual)

196

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients who are wearing removable partial dentures constructed by staff or students at the Prince Philip Dental Hospital are recruited

Exclusion Criteria:

  • If they have less than 4 teeth in any dental arch, have advanced periodontal disease in 2 or more sextants, have received therapeutic radiation of the head and neck region, have concurrent systemic illness that alters salivary flow, or have participated in a clinical trial within 6 months before the commencement of participation in this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Silver diamine fluoride
38% silver diamine fluoride solution (Saforide, Toyo Seiyaku Kasei Co. Ltd., Osaka, Japan) is professionally applied to exposed coronal and root surfaces of all teeth every 6 months for 36 months.
Silver diamine fluoride solution is applied to the dried and exposed coronal and root surfaces of all teeth by means of a disposable microbrush.
Other Names:
  • Saforide
Placebo Comparator: Distilled water
Distilled water is professionally applied to exposed coronal and root surfaces of all teeth every 6 months for 36 months.
Distilled water is applied to the dried and exposed coronal and root surfaces of all teeth by means of a disposable microbrush.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Caries increment
Time Frame: 36 months
New and recurrent caries lesions are recorded according to the International Caries Detection and Assessment System (ICDAS). Molars and premolars are considered to have 5 coronal surfaces, whereas canines and incisors are considered to have 4. The cleaned and dried teeth are recorded as sound, sealed, restored, crowned, or missing. Each coronal tooth surface is classified using a 7-point ordinal scale ranging from sound to extensive cavitation using a WHO probe. The same procedure is repeated for all root surfaces. Coronal and root surface caries increments are calculated by comparing the baseline and follow-up observations for each tooth surface.
36 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of oral colonization of oral yeasts
Time Frame: 36 months
The prevalence of oral yeast in oral rinse and dental plaque is counted. Prevalence is expressed as percentage of the participants.
36 months
Colonization of oral yeasts in oral rinse
Time Frame: 36 months
The count of oral yeasts in oral rinse is recorded. The count of oral yeast in oral rinse is expressed as colony-forming unit (cfu)/ml.
36 months
Colonization of oral yeasts in dental plaque
Time Frame: 36 months
The count of oral yeasts in dental plaque is recorded. The count of oral yeast in dental plaque is expressed as cfu/g.
36 months
Prevalence of oral colonization of Streptococcus mutans (S. mutans)
Time Frame: 36 months
The prevalence S. mutans in stimulated whole saliva (SWS) and dental plaque is counted. Prevalence is expressed as percentage of the participants.
36 months
Colonization of S. mutans in saliva
Time Frame: 36 months
The count of S. mutans in SWS is recorded. The count of S. mutans in SWS is expressed as cfu/ml.
36 months
Colonization of S. mutans in dental plaque
Time Frame: 36 months
The count of S. mutans dental plaque is recorded. The count of S. mutans in dental plaque is expressed as cfu/g.
36 months
Prevalence of oral colonization of lactobacilli
Time Frame: 36 months
The prevalence of lactobacilli in SWS and dental plaque is counted. Prevalence is expressed as percentage of the participants.
36 months
Colonization of lactobacilli in saliva
Time Frame: 36 months
The count of lactobacilli in SWS is recorded. The count of lactobacilli in SWS is expressed as cfu/ml.
36 months
Colonization of lactobacilli in dental plaque
Time Frame: 36 months
The count of lactobacilli in dental plaque is recorded. The count of lactobacilli in dental plaque is expressed as cfu/g.
36 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Katherine CM Leung, BDS,MDS, PhD, Faculty of Dentistry, The University of Hong Kong

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2013

Primary Completion (Anticipated)

June 30, 2017

Study Completion (Anticipated)

December 31, 2017

Study Registration Dates

First Submitted

April 24, 2017

First Submitted That Met QC Criteria

June 9, 2017

First Posted (Actual)

June 14, 2017

Study Record Updates

Last Update Posted (Actual)

June 14, 2017

Last Update Submitted That Met QC Criteria

June 9, 2017

Last Verified

June 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Caries

Clinical Trials on Silver Diamine Fluoride

3
Subscribe